HCID 135681577, compound → HCID 135681640, compound
Reaction equation
[Cl:1][C:2]1[CH:3]=[C:4]([CH:8]([OH:31])[CH2:9][NH:10][C:11]2[CH:16]=[CH:15][NH:14][C:13](=[O:17])[C:12]=2[C:18]2[NH:19][C:20]3[CH:26]=[C:25]([C:27]([NH2:29])=O)[CH:24]=[C:23]([CH3:30])[C:21]=3[N:22]=2)[CH:5]=[CH:6][CH:7]=1>C1COCC1>[NH2:29][CH2:27][C:25]1[CH:24]=[C:23]([CH3:30])[C:21]2[N:22]=[C:18]([C:12]3[C:13](=[O:17])[NH:14][CH:15]=[CH:16][C:11]=3[NH:10][CH2:9][CH:8]([C:4]3[CH:5]=[CH:6][CH:7]=[C:2]([Cl:1])[CH:3]=3)[OH:31])[NH:19][C:20]=2[CH:26]=1Participants
Reactant 1
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of (±)-2-{4-[2-(3-Chloro-phenyl)-2-hydroxy-ethylamino]-2-oxo-1,2-dihydro-pyridin-3-yl}-7-methyl-3H-benzimidazole-5-carboxylic acid amide (20 mg, 0.046 mmol) in THF (1 mL) was added borane-tetrahydrofuran complex (1 M solution) (0.45 mL, 0.45 mmol). The reaction mixture was stirred at room temperature for 10 h and quenched with acetic acid (2 drops). After removal of most solvent, the residue was extracted with EtOAc, washed with brine, dried over Na2SO4. After concentration, the crude product was purified by prep. HPLC to yield the title compound (11.5 mg, 60%). 1H NMR (400 MHz, CD3OD) δ 7.53 (1H, s), 7.50 (1H, s), 7.39 (1H, d, J=7.5 Hz), 7.24–7.32 (3H, m), 7.13 (1H, s), 6.26 (1H, d, J=7.5 Hz), 4.99 (1H, dd, J=4.8, 6.8 Hz), 4.19 (2H, s), 3.72 (1H, dd, J=4.8, 13.6 Hz), 3.64 (1H, dd, J=6.8, 13.6 Hz), 2.62 (3H, s). LCMS (M+H)+ m/z 424 (t=2.10 min.).
Workup
- customquenched with acetic acid (2 drops)
- customAfter removal of most solvent
- extractionthe residue was extracted with EtOAc
- washwashed with brine
- dry with materialdried over Na2SO4
- concentrationAfter concentration
- customthe crude product was purified by prep
Sources & evidence
- ORD record
- ord-0d0a5a5fb8354933a6c3a95b822257da
- Source dataset
- uspto-grants-2007_05
- Patent number
- US07223757B2
Reaction notes
Loading…